• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Successful outcome of assisted reproductive technology in women with polycystic ovary syndrome combined with empty follicle syndrome: A case report.多囊卵巢综合征合并空卵泡综合征患者辅助生殖技术的成功结局:一例报告
Medicine (Baltimore). 2025 Jun 27;104(26):e43001. doi: 10.1097/MD.0000000000043001.
2
Randomized controlled trial to evaluate the impact of follicle priming on IVM outcomes in women with polycystic ovaries: CFA versus FSH-B.评估卵泡预处理对多囊卵巢女性体外成熟结局影响的随机对照试验:克罗米芬加促性腺激素释放激素拮抗剂方案与促卵泡生成素加促性腺激素释放激素拮抗剂方案的比较
Hum Reprod. 2025 Jun 1;40(6):1127-1137. doi: 10.1093/humrep/deaf053.
3
Gonadotropins for ovulation induction in women with polycystic ovary syndrome.用于多囊卵巢综合征女性促排卵的促性腺激素。
Cochrane Database Syst Rev. 2025 Apr 7;4(4):CD010290. doi: 10.1002/14651858.CD010290.pub4.
4
Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.芳香化酶抑制剂(来曲唑)用于多囊卵巢综合征的不孕女性。
Cochrane Database Syst Rev. 2018 May 24;5(5):CD010287. doi: 10.1002/14651858.CD010287.pub3.
5
Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.促性腺激素疗法用于多囊卵巢综合征相关不孕症的排卵诱导
Cochrane Database Syst Rev. 2000(4):CD000410. doi: 10.1002/14651858.CD000410.
6
Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis.辅助生殖的控制性卵巢刺激方案:一项网状荟萃分析。
Cochrane Database Syst Rev. 2025 Jul 1;7(7):CD012586. doi: 10.1002/14651858.CD012586.pub2.
7
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.用于患有多囊卵巢综合征、月经过少和生育力低下的女性的胰岛素增敏药物(二甲双胍、罗格列酮、吡格列酮、D-手性肌醇)。
Cochrane Database Syst Rev. 2017 Nov 29;11(11):CD003053. doi: 10.1002/14651858.CD003053.pub6.
8
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.芳香化酶抑制剂(来曲唑)在多囊卵巢综合征不孕妇女中的促排卵作用。
Cochrane Database Syst Rev. 2022 Sep 27;9(9):CD010287. doi: 10.1002/14651858.CD010287.pub4.
9
Does metformin improve reproduction outcomes for non-obese, infertile women with polycystic ovary syndrome? Meta-analysis and systematic review.二甲双胍是否能改善非肥胖型多囊卵巢综合征不孕妇女的生殖结局?荟萃分析和系统评价。
Eur J Obstet Gynecol Reprod Biol. 2022 Apr;271:38-62. doi: 10.1016/j.ejogrb.2022.01.025. Epub 2022 Feb 1.
10
Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.腹腔镜下使用透热疗法或激光“打孔”以诱导无排卵性多囊卵巢综合征患者排卵。
Cochrane Database Syst Rev. 2000(2):CD001122. doi: 10.1002/14651858.CD001122.

本文引用的文献

1
Might retrigger with human chorionic gonadotropin be a solution for empty follicle syndrome after gonadotropin releasing hormone agonist trigger?
Turk J Obstet Gynecol. 2024 Sep 4;21(3):135-141. doi: 10.4274/tjod.galenos.2024.80439.
2
Risk factors, management, and future fertility of empty follicle syndrome: a retrospective study with real-world data.空卵泡综合征的风险因素、管理和未来生育能力:一项基于真实世界数据的回顾性研究。
Front Endocrinol (Lausanne). 2024 Jul 11;15:1424837. doi: 10.3389/fendo.2024.1424837. eCollection 2024.
3
Risk factors for poor oocyte yield and oocyte immaturity after GnRH agonist triggering.GnRH激动剂触发后卵母细胞产量低和卵母细胞不成熟的危险因素。
Hum Reprod. 2024 May 2;39(5):963-973. doi: 10.1093/humrep/deae041.
4
Disturbed Follicular Microenvironment in Polycystic Ovary Syndrome: Relationship to Oocyte Quality and Infertility.多囊卵巢综合征中滤泡微环境的紊乱:与卵母细胞质量和不孕的关系。
Endocrinology. 2024 Feb 20;165(4). doi: 10.1210/endocr/bqae023.
5
Significance of LHCGR polymorphisms in polycystic ovary syndrome: an association study.LHCGR 多态性在多囊卵巢综合征中的意义:一项关联研究。
Sci Rep. 2023 Dec 21;13(1):22841. doi: 10.1038/s41598-023-48881-0.
6
The efficacy and safety of beinaglutide alone or in combination with insulin glargine in Chinese patients with type 2 diabetes mellitus who are inadequately controlled with oral antihyperglycemic therapy: A multicenter, open-label, randomized trial.在中国口服降糖治疗控制不佳的2型糖尿病患者中,贝那鲁肽单药治疗或与甘精胰岛素联合治疗的疗效和安全性:一项多中心、开放标签、随机试验。
J Diabetes. 2023 Oct 20;16(2). doi: 10.1111/1753-0407.13483.
7
Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.2023 年多囊卵巢综合征评估和管理国际循证指南推荐。
J Clin Endocrinol Metab. 2023 Sep 18;108(10):2447-2469. doi: 10.1210/clinem/dgad463.
8
Risk factors for low oocyte retrieval in patients with polycystic ovarian syndrome undergoing in vitro fertilization.多囊卵巢综合征患者行体外受精时卵母细胞获取率低的风险因素。
Reprod Biol Endocrinol. 2023 Jul 19;21(1):66. doi: 10.1186/s12958-023-01118-1.
9
Short-term effect of beinaglutide combined with metformin versus metformin alone on weight loss and metabolic profiles in obese patients with polycystic ovary syndrome: a pilot randomized trial.贝那鲁肽联合二甲双胍对比二甲双胍单药治疗多囊卵巢综合征肥胖患者的短期减重效果及代谢谱的影响:一项随机试验。
Front Endocrinol (Lausanne). 2023 Jun 6;14:1156521. doi: 10.3389/fendo.2023.1156521. eCollection 2023.
10
Polycystic ovary syndrome.多囊卵巢综合征。
Lancet Diabetes Endocrinol. 2022 Sep;10(9):668-680. doi: 10.1016/S2213-8587(22)00163-2. Epub 2022 Aug 4.

多囊卵巢综合征合并空卵泡综合征患者辅助生殖技术的成功结局:一例报告

Successful outcome of assisted reproductive technology in women with polycystic ovary syndrome combined with empty follicle syndrome: A case report.

作者信息

Guo Danyang, Zhang Lin, Lin Xiaoxia, Tang Sha, Zhang Bin, Ni Linlin

机构信息

The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province, China.

Dongying People's Hospital, Dongying, Shandong Province, China.

出版信息

Medicine (Baltimore). 2025 Jun 27;104(26):e43001. doi: 10.1097/MD.0000000000043001.

DOI:10.1097/MD.0000000000043001
PMID:40587668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12212853/
Abstract

RATIONALE

Empty follicle syndrome (EFS) is a rare and difficult-to-treat condition. Obese polycystic ovary syndrome (PCOS) is considered an independent risk factor for it. In this study, we report a case of successful pregnancy in an obese patient with PCOS combined with EFS and discuss the pathogenesis of EFS and optimal treatment strategies.

PATIENT CONCERNS

A 25-year-old woman presents with "6 years of infertility without contraception."

DIAGNOSES

Primary infertility, bilateral fallopian tube obstruction, PCOS, and EFS.

INTERVENTIONS

The patient underwent 2 cycles of controlled ovarian stimulation. In the first cycle, despite adequate ovarian stimulation, oocytes were not obtained and a diagnosis of EFS was made. In the second cycle, the following optimization measures were taken: the use of beinaglutide to help the patient lose weight and improve her blood glucose levels, supplementation with luteinizing hormone-active medications (e.g., Menotropins for injection), an increase in the dose of human chorionic gonadotropin, and the addition of growth hormone to improve the outcome of oocytes retrieval once the patient's blood glucose levels had stabilized.

OUTCOMES

In the second cycle, 15 oocytes were successfully obtained, 13 oocytes of which were Metaphase II, resulting in the culture of 5 high-quality embryos. The patient had a successful pregnancy after frozen embryo transfer and was followed up to late-term pregnancy without abnormalities.

LESSONS

Multiple complex mechanisms may be involved in the development of EFS, and preconditioning and individualized treatment protocols are essential for improving outcomes in patients with EFS. Our treatment protocol provides some reference basis for the treatment of EFS.

摘要

理论依据

空卵泡综合征(EFS)是一种罕见且难以治疗的病症。肥胖型多囊卵巢综合征(PCOS)被认为是其独立危险因素。在本研究中,我们报告了一例肥胖型PCOS合并EFS患者成功妊娠的病例,并探讨了EFS的发病机制及最佳治疗策略。

患者情况

一名25岁女性因“未避孕6年不孕”就诊。

诊断结果

原发性不孕、双侧输卵管阻塞、PCOS和EFS。

干预措施

患者接受了2个周期的控制性卵巢刺激。在第一个周期中,尽管卵巢刺激充分,但未获取到卵母细胞,诊断为空卵泡综合征。在第二个周期中,采取了以下优化措施:使用贝那鲁肽帮助患者减重并改善血糖水平,补充促黄体生成素活性药物(如注射用尿促性素),增加人绒毛膜促性腺激素剂量,待患者血糖水平稳定后添加生长激素以提高取卵效果。

治疗结果

在第二个周期中,成功获取15个卵母细胞,其中13个处于减数分裂中期II,共培养出5个优质胚胎。患者在冻融胚胎移植后成功妊娠,并随访至妊娠晚期无异常。

经验教训

EFS的发生可能涉及多种复杂机制,预处理和个体化治疗方案对于改善EFS患者的治疗效果至关重要。我们的治疗方案为EFS的治疗提供了一些参考依据。